Research & Discovery
Turning to Old Remedies For New Health Challenges
UConn researchers are experimenting with old approaches to solve a growing problem: potentially deadly pathogens that are resistant to antibiotics.
Meet the Researcher: Samantha Siedlecki, Marine Sciences
Samantha Siedlecki spearheads research on coastal environments, and is currently developing a regional model of ocean acidification for the East Coast.
Not Only Adorable: Squid Open Up New Antimicrobial Drug Possibilities
The glowing Hawaiian bobtail squid is more than a pretty face: New research shows that its symbiotic bacteria create antifungal compounds, which may be of use in drug discovery.
Breaking CO2 faster, cheaper, and more efficiently
A new discovery could make it possible to economically turn carbon dioxide into fuels.
Q&A: The Dangers of Vaping
UConn Health’s Dr. Mario F Perez, assistant professor of medicine at UConn School of Medicine, discusses his research pointing to potential dangers associated with vaping.
The Heart of the Matter: Genome Editing for Cardiovascular Diseases
Joint researcher from UConn Health and JAX, J. Travis Hinson's $3M grant is a pivotal step toward realizing the promise of genome editing and human precision medicine of cardiovascular and other disorders.
Deeper Than Our Bones, Targeting the Genes Responsible for Skeletal Conditions
UConn Health researcher Dr. Ernesto Canalis has received a grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases to investigate whether he can silence mutant genes responsible for serious skeletal diseases.
Race, Place, and the Uneven Distribution of Black or Hispanic Educators in CT
Editor’s Note: Jeremy B. Landa, Neag School doctoral student in the Learning, Leadership, and Education Policy program, prepared the following issue brief — in affiliation with the Center for Education Policy Analysis (CEPA) — exploring the distribution of Black or Hispanic educators across Connecticut’s school districts.
Hometown Advantage? CEOs Tend to Acquire Companies in Familiar Stomping Grounds
Companies are 2.5 times more likely to acquire firms headquartered in the state where their CEO grew up than similar firms located elsewhere, says new study.
Nami Therapeutics Startup Pursues Promising Drug Therapy
Nami Therapeutics, a collaboration by UConn and the University of North Carolina, is developing a tumor-specific radioactive therapy designed to specifically target ovarian cancer.